Skip to content

Beam 制药

US · BEAM #2614 按市值排名 上市于 2020
23.47 -1.26 -5.10%
实时 - 追踪5344个代码 - 心跳于240秒前 · 2026-10-16 20:02

✦ 量化股权信号 计算方式说明

减持
  • 最近一期（2026/Q3）披露持股的机构数量减少了1家。
  • 机构持股总比例下降了4.3个百分点。

机构持股

机构持股比例
106.66% -4.33pp
机构数量
337 -1
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund73.43%
Hedge Fund18.62%
VC/PE Fund8.43%
Public Company3.52%
Private Company1.89%
Individual/Insider1.36%
Government Pension Fund0.36%
Family Office/Trust0.28%
Insurance Company0.13%

主要股东 截至 2026-06-30

FMR 11.76% · 11.75M 股
Farallon Capital Management, L.L.C. 10.24% · 10.24M 股
ARK Investment Management LLC 10.24% · 10.23M 股
BlackRock 9.00% · 9.00M 股
State Street Global Advisors 5.83% · 5.83M 股
Vanguard Capital Management, LLC 5.31% · 5.31M 股
Vanguard Portfolio Management, LLC 4.92% · 4.92M 股
Arch Venture Partners, L.P. 4.54% · 4.54M 股
Amova Asset Management 3.46% · 3.46M 股
T. Rowe Price Group, Inc. 3.42% · 3.42M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 20次买入 · 30次卖出

姓名职务持股比例
FMR -- 11.76%
John Evans Chief Executive Officer 0.95%
Giuseppe Ciaramella President 0.17%
Christine Bellon Chief Legal Officer 0.11%
Robert Taylor Nelsen Former Independent Director 0.06%
Mark Fishman Independent Director 0.02%
Bethany Cavanagh Senior VP of Finance & Treasurer 0.01%
Sravan Emany Chief Financial Officer 0.01%
Amy Simon Chief Medical Officer 0.00%
John Michael Maraganore Independent Director --

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-30 Bethany Cavanagh Senior VP of Finance & Treasurer Automatic Disposition -187 $24.41
2026-09-23 Giuseppe Ciaramella President Other Disposition -123,407 --
2026-07-26 Amy Simon Chief Medical Officer Automatic Disposition -16,667 $25.74
2026-06-29 John Evans Chief Executive Officer Derivative Exercise and Sale -50,000 $0.67–35.91
2026-06-29 John Evans Chief Executive Officer Intent to Sell (Form 144) -25,000 $34.31
2026-06-29 Amy Simon Chief Medical Officer Automatic Disposition -373 $34.73
2026-06-28 John Evans Chief Executive Officer Intent to Sell (Form 144) -25,000 $35.49
2026-06-16 Giuseppe Ciaramella President Derivative Exercise and Retained +35,505 $0.67–1.03
2026-06-02 John Michael Maraganore Independent Director Other Derivative Acquisition +19,676 $29.55
2026-06-02 Mark Fishman Independent Director Other Derivative Acquisition +19,676 $29.55
2026-06-02 Graham Cooper Independent Director Other Derivative Acquisition +19,676 $29.55
2026-06-02 Kathleen Walsh Independent Director Other Derivative Acquisition +19,676 $29.55
2026-06-02 Chirfi Guindo Director Other Derivative Acquisition +19,676 $29.55
2026-06-02 Christi Shaw Director Other Derivative Acquisition +19,676 $29.55
2026-04-13 Carole Ho Independent Director Intent to Sell (Form 144) -87,784 $30.73
2026-04-01 Christine Bellon Chief Legal Officer Intent to Sell (Form 144) -20,000 $21.90
2026-04-01 John Evans Chief Executive Officer Intent to Sell (Form 144) -66,874 $21.90
2026-04-01 Giuseppe Ciaramella President Intent to Sell (Form 144) -26,250 $21.90
2026-04-01 Amy Simon Chief Medical Officer Intent to Sell (Form 144) -20,000 $21.90
2026-03-31 Christine Bellon Chief Legal Officer Automatic Disposition -5,956 $24.58

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:02:27 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

Beam 制药 讨论区 0 条评论

发表评论